These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 212377)

  • 61. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
    Menezes J; Leibold W; Klein G; Clements G
    Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.
    Nakagomi H; Dolcetti R; Bejarano MT; Pisa P; Kiessling R; Masucci MG
    Int J Cancer; 1994 Apr; 57(2):240-4. PubMed ID: 8157362
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
    Szigeti R; Rabin H; Timar L; Klein G
    Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin.
    Shapiro IM; Luka J; Andersson-Anvret M; Klein G
    Intervirology; 1979; 12(1):19-25. PubMed ID: 227812
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analysis of the transformation of human lymphocytes by Epstein-Barr virus III. Induction of early events by P3HR-1 strain without subsequent immortalization.
    Takada K; Osato T
    Med Microbiol Immunol; 1981; 170(1):19-26. PubMed ID: 6272076
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein.
    Qualtiere LF; Chase R; Vroman B; Pearson GR
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunologic identification of Epstein-Barr virus early antigen in a P3HR-1 cell extract.
    Veltri RW; Wainwright WH; Sprinkle PM
    J Natl Cancer Inst; 1976 Aug; 57(2):245-53. PubMed ID: 187767
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential inducibility of Epstein-Barr virus in cloned, non-producer Raji cells.
    Bister K; Yamamoto N; zur Hausen H
    Int J Cancer; 1979 Jun; 23(6):818-25. PubMed ID: 89100
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular size variation of EBNA is determined by the EB viral genome.
    Gergely L; Sternås L; Dillner J; Klein G
    Intervirology; 1984; 22(2):85-96. PubMed ID: 6090339
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens.
    Salahuddin SZ; Ablashi DV; Hunter EA; Gonda MA; Sturzenegger S; Markham PD; Gallo RC
    Int J Cancer; 1987 Feb; 39(2):198-202. PubMed ID: 3026971
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interaction of the B95-8 and P3HR-1 substrains of Epstein-Barr virus (EBV) with peripheral human lymphocytes.
    Steinitz M; Bakács T; Klein G
    Int J Cancer; 1978 Sep; 22(3):251-7. PubMed ID: 212371
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
    Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
    J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential induction of Epstein-Barr virus-related antigens in human lymphoblastoid cells by virus-mediated cell-to-cell contact.
    Matsuo T; Yamamoto K; Osato T
    Int J Cancer; 1976 Apr; 17(4):423-8. PubMed ID: 179955
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines.
    Klein G; Zeuthen J; Terasaki P; Billing R; Honig R; Jondal M; Westman A; Clements G
    Int J Cancer; 1976 Nov; 18(5):639-52. PubMed ID: 62724
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Detection of intracellular herpes virus antigens by immuno-enzyme procedures].
    Kurstak E; Kurstak C; Morisset R
    Dev Biol Stand; 1982; 52():187-91. PubMed ID: 6299829
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epstein-Barr virus with heterogeneous DNA disrupts latency.
    Miller G; Rabson M; Heston L
    J Virol; 1984 Apr; 50(1):174-82. PubMed ID: 6321789
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Steroids inhibit tumor promoting agent induced Epstein-Barr virus early antigens in Raji cells.
    Sundar SK; Ablashi DV; Armstrong GR; Zipkin M; Faggioni A; Levine PH
    Int J Cancer; 1981 Oct; 28(4):503-7. PubMed ID: 6273335
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens.
    Reedman BM; Hilgers J; Hilgers F; Klein G
    Int J Cancer; 1975 Apr; 15(4):566-71. PubMed ID: 166941
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus.
    Klein G; Falk L; Falk K
    Intervirology; 1978; 10(3):153-64. PubMed ID: 210135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.